It suppresses cell proliferation and the transition from the G0/G1 phase to the S phase in bladder cancer by suppressing the expression of carbonic anhydrase IX (CA9), thereby diminishing tumor formation (Zhang P. et al., 2023). The gene discussed is CA9; the disease is urinary bladder cancer.